BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2026 6:38:37 AM | Browse: 4 | Download: 0
 |
Received |
|
2026-01-02 14:39 |
|
Peer-Review Started |
|
2026-01-02 14:41 |
|
First Decision by Editorial Office Director |
|
2026-01-19 08:59 |
|
Return for Revision |
|
2026-01-19 08:59 |
|
Revised |
|
2026-02-02 10:09 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-03 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-03 06:56 |
|
Articles in Press |
|
2026-03-03 06:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-19 03:10 |
|
Publish the Manuscript Online |
|
2026-08-25 06:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Editorial |
| Article Title |
Integrating hepatitis C care into human immunodeficiency virus clinics in the direct-acting antiviral era: From biological disadvantage to structural opportunity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tian-Ju Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chongqing public health key specialty project |
|
| the Natural Science Foundation of Chongqing Municipality |
No. Cstc2021jcyj-msxmX1219 |
|
| Corresponding Author |
Tian-Ju Li, PhD, Department of Infectious Diseases, Beibei Affiliated Hospital of Chongqing Medical University, No. 69 Jialing Village, Beibei District, Chongqing 400700, China. tianjulee@126.com |
| Key Words |
Integrated care; Liver disease severity; Direct-acting antivirals; Hepatitis C virus; Human immunodeficiency virus |
| Core Tip |
Earlier histologic studies from the interferon-based treatment era suggested that HIV coinfection worsened hepatitis C virus (HCV) outcomes. In comparison, recent evidence from Park et al in the DAA era indicates that achieving sustained virologic response abolishes survival differences between individuals living with HIV/HCV and those with HCV monoinfection. Residual adverse outcomes now arise primarily from attrition across the care cascade and from metabolic and non–liver-related risks after cure, rather than from ongoing viral effects. Accordingly, implementing integrated care models within HIV clinics, coupled with long-term metabolic surveillance, is essential to translate virologic cure into durable survival benefits. |
| Publish Date |
2026-08-25 06:38 |
| Citation |
Li TJ. Integrating hepatitis C care into human immunodeficiency virus clinics in the direct-acting antiviral era: From biological disadvantage to structural opportunity. World J Gastroenterol 2026; 32(36): 118426
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i36/118426.htm |
| DOI |
https://doi.org/10.3748/wjg.118426 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
